Brief: HHS Project Nextgen Selects Initial Vaccine Candidates And Awards Over $500 Million To Advance Development Of Vaccines And Therapeutics
Oct 13 (Reuters) - Gritstone bio Inc GRTS.O :
* HHS: PROJECT NEXTGEN SELECTS INITIAL VACCINE CANDIDATES
AND
AWARDS OVER $500 MILLION TO ADVANCE DEVELOPMENT OF VACCINES AND
THERAPEUTICS
* HHS: VACCINE SELECTION BRINGS PRODUCTS CLOSER TO CLINICAL
TRIALS
SLATED TO BEGIN AS EARLY AS THIS WINTER
Source text for Eikon: ID:
Further company coverage: GRTS.O
((Reuters.Briefs@thomsonreuters.com ;))
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy